Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 4/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1780825 | 0.78 | HSPD1 (0.38) | CYP3A4TSHRATMTDP1CA2 | |
| SCHEMBL429557 | 0.77 | HSPD1 (0.38) | CA2MAPK1MEN1HPGDRECQL | |
| SCHEMBL23199562 | 0.76 | MEN1 (0.33) | CYP3A4TSHRATMTDP1CA2 | |
| SCHEMBL5284698 | 0.76 | CYP3A4 (0.37) | CYP3A4TSHRATMTDP1CA2 | |
| SCHEMBL11316590 | 0.75 | HSPD1 (0.41) | CYP3A4TSHRATMTDP1CA2 | |
| SCHEMBL5475897 | 0.74 | CA2 (0.41) | CYP3A4TSHRATMTDP1CA2 | |
| SCHEMBL3394206 | 0.73 | HSPD1 (0.47) | CYP3A4TSHRATMTDP1CA2 | |
| SCHEMBL1460183 | 0.73 | CYP3A4 (0.39) | CYP3A4TSHRATMTDP1CA2 | |
| SCHEMBL4733030 | 0.73 | HSPD1 (0.43) | MEN1HPGDRECQLKMT2AHSD17B10 | |
| SCHEMBL2462628 | 0.72 | HSPD1 (0.39) | CYP3A4TSHRATMTDP1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 238 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12532952-B2 | Light-curable artificial nails, methods of preparation and methods of use thereof | Brilliance of Beauty, Inc. (US) | 2026-01-27 | — | — | US | claimed |
| US-20240398092-A1 | LIGHT-CURABLE ARTIFICIAL NAILS, METHODS OF PREPARATION AND METHODS OF USE THEREOF | Brilliance of Beauty, Inc. | 2024-12-05 | — | — | US | claimed |
| EP-4374736-A2 | LIGHT-CURABLE ARTIFICIAL NAILS, METHODS OF PREPARATION AND METHODS OF USE THEREOF | Brilliance of Beauty, Inc. (US) | 2024-05-29 | — | — | EP | claimed |
| EP-4216753-B1 | LIGHT-CURABLE ARTIFICIAL NAILS, METHODS OF PREPARATION AND METHODS OF USE THEREOF | BRILLIANCE OF BEAUTY INC (US) | 2024-05-22 | — | — | EP | claimed |
| EP-4216753-A1 | LIGHT-CURABLE ARTIFICIAL NAILS, METHODS OF PREPARATION AND METHODS OF USE THEREOF | Brilliance of Beauty, Inc. (US) | 2023-08-02 | — | — | EP | claimed |
| US-20220232945-A1 | LIGHT-CURABLE ARTIFICIAL NAILS, METHODS OF PREPARATION AND METHODS OF USE THEREOF | Brilliance of Beauty, Inc. | 2022-07-28 | — | — | US | claimed |
| US-11330888-B1 | Light-curable artificial nails, methods of preparation and methods of use thereof | Brilliance of Beauty, Inc. (US) | 2022-05-17 | — | — | US | claimed |
| WO-2022098883-A1 | LIGHT-CURABLE ARTIFICIAL NAILS, METHODS OF PREPARATION AND METHODS OF USE THEREOF | Brilliance of Beauty, Inc. (US) | 2022-05-12 | — | — | WO | claimed |
| US-20220133013-A1 | LIGHT-CURABLE ARTIFICIAL NAILS, METHODS OF PREPARATION AND METHODS OF USE THEREOF | Brilliance of Beauty, Inc. | 2022-05-05 | — | — | US | claimed |
| CN-109021520-A | A kind of high-isolating packaging film and preparation method thereof that strength and toughness is good | 常德金德新材料科技股份有限公司 | 2018-12-18 | — | — | CN | claimed |
| CN-103031558-A | Metal antirust agent containing ammonium molybdate | TONGLING DONGFANG MINING MACHINE CO LTD | 2013-04-10 | — | — | CN | claimed |
| CN-102993878-A | Metal rust inhibitor containing diacetyl triethyl citrate | ANHUI RONGDA VALVE CO LTD | 2013-03-27 | — | — | CN | claimed |
| CN-102993877-A | Metal rust inhibitor containing sodium dodecyl sulfate | ANHUI RONGDA VALVE CO LTD | 2013-03-27 | — | — | CN | claimed |
| CN-102993817-A | Metal rust inhibitor containing peregal O | ANHUI RONGDA VALVE CO LTD | 2013-03-27 | — | — | CN | claimed |
| CN-102977669-A | Preparation method of metal antirust agent containing styrylphenol polyoxyethylene ether | TONGLING MINGCHENG CASTING CO LTD | 2013-03-20 | — | — | CN | claimed |
| CN-102977717-A | Metal antirust agent | TONGLING MINGCHENG CASTING CO LTD | 2013-03-20 | — | — | CN | claimed |
| CN-102977718-A | Metal antirust agent containing 2-ethylimidazoline | TONGLING MINGCHENG CASTING CO LTD | 2013-03-20 | — | — | CN | claimed |
| CN-102977719-A | Metal antirust agent having long antirust time and containing sodium diacetate | TONGLING MINGCHENG CASTING CO LTD | 2013-03-20 | — | — | CN | claimed |
| EP-1862225-A1 | Pencil with a sharpenable wrapping and a gripping area on the surface of the pencil | Faber-Castell AG (DE) | 2007-12-05 | — | — | EP | claimed |
| EP-1566401-A2 | Plastic material for kneading, modelling and decorating and preparation thereof | J.S. Staedtler GmbH & Co KG (DE) | 2005-08-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12532952-B2 | Light-curable artificial nails, methods of preparation and methods of use thereof | KRT18, FLNA, CUTA | CYP3A4 3227/4885TSHR 1256/4885ATM 361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.